Steven Engle, CEO, CohBar, a clinical stage biotechnology company, is developing mitochondria-based therapeutics to treat chronic diseases and extend healthy lifespan which tackle the challenges of aging and prevent or delay the onset of age-related diseases including cancer, Alzheimer’s and heart disease. He is a guest on One America News Networks interviewed by Stephanie Myers on April 14th 2021.
Investing in Longevity – Mitochondria Based Therapeutics
